Lloyds buys newsagents from C&C receivers
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.LLOYDS CHEMISTS, the chain of pharmacists built up by Allen Lloyd, has bought 89 newsagents from the receivers to Cavendish & Castle.
The 89 outlets, selected from C&C's portfolio of 140 shops, cost less than pounds 5m. They have been earmarked for conversion either to Holland & Barrett healthfood shops or to Supersave drugstores, both owned by Lloyds.
Allen Lloyd, chairman, stressed that his company was not planning to enter the newsagency business but would trade the profitable outlets as they were until conversion, expected to be completed within 18 months.
Lloyds has grown swiftly by acquisition during the past three years. In prescription chemist shops, with 864 outlets, it is second to Boots.
The shops bought yesterday will be added in equal measure to the Holland & Barrett and Supersave parts of the operation.
The C&C purchase comes less than six months after Lloyds bought Macarthy's, another chemist chain for pounds 96m.
The shares fell 6p to 280p as the stock market digested the news.
Lloyds' shares have fallen in the past 10 days as fears have spread about changes to pricing of NHS drugs to chemists.
Mr Lloyd said yesterday that chemists' profit margins were under constant pressure from the Government, but efficiencies were to be won else where.
Lloyds' own stockbroker, Panmure Gordon, said the price list changes would be broadly neutral.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments